Jitendra Singh

Jitendra Singh

Active Director Director DIN 08688870
DIN 08688870 First appointment Feb 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value •••• Premium profile

About Jitendra Singh

Data last updated:

Jitendra Singh is a Director at Cureschil Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Cureschil Pharmaceuticals Private Limited reported revenue of ₹1.13 Cr (FY 2025).

DIN 08688870
Primary Designation Director
Industry Chemicals
First Appointment 04 Feb 2020
Oldest Company Age 6 yrs
Largest company Cureschil Pharmaceuticals Private Limited · ₹1.13 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20202020₹1.13 Cr (FY 2025)Active

Board colleagues of Jitendra Singh

Directorship timeline

Open interactive timeline →
Cureschil Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jitendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Singh

Jitendra Singh currently holds 1 directorship: Cureschil Pharmaceuticals Private Limited (Director, since 04 Feb 2020, revenue ₹1.13 Cr (FY 2025)).

Jitendra Singh was first appointed on 04 Feb 2020 as Director at Cureschil Pharmaceuticals Private Limited.

The current boards of Jitendra Singh's companies include Arti Trivedi (Cureschil Pharmaceuticals Private Limited), Vishwa Nath Singh (Cureschil Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available